Cathie Wood Stock Portfolio: 5 Newest Stock Picks This Year

Page 5 of 5

1. Guardant Health, Inc. (NASDAQ:GH)

Ark Investment’s Stake Value: $29 million

Percentage of Ark Investment’s 13F Portfolio: 0.2%

Number of Hedge Fund Holders: 35

Guardant Health, Inc. (NASDAQ:GH) is an American healthcare diagnostics firm. It offers services such as biopsy tests for cancer, blood tests, and the coronavirus. The firm is headquartered in Redwood City, California.

Cathie Wood’s investment firm bought 542,113 Guardant Health, Inc. (NASDAQ:GH) shares during the third quarter of this year, allowing it to hold a $29 million stake in the company. In the prior quarter, 35 out of the 895 hedge funds polled by Insider Monkey had invested in the company.

Guardant Health, Inc. (NASDAQ:GH)’s Guardant360 liquid biopsy test was approved by the Food and Drug Administration in August 2022. This test identifies lung cancer patients that can be treated with ENHERTU’s Enhertu cancer drug. The firm brought in $400 million revenue in June 2022, with the FDA approval providing more revenue opportunities.

Guardant Health, Inc. (NASDAQ:GH)’s largest investor in our database is Andreas Halvorsen’s Viking Global which owns 4.4 million shares that are worth $180 million.

Disclosure: None. You can also take a look at 10 Best LNG Stocks To Buy and 11 Best Cyclical Stocks To Buy.

Page 5 of 5